49 participants
Comparing the Addition of an Anti-Cancer Drug, Pomalidomide, to the Usual Chemotherapy Treatment (Daunorubicin and Cytarabine Liposome) in Newly Diagnosed Acute Myeloid Leukemia With Myelodysplastic Syndrome-Related Changes
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2026-06-30
- Start Date:
- 2022-08-24
- Completion:
- 2024-11-21
Conditions
- Acute Myeloid Leukemia
- Acute Myeloid Leukemia Post Cytotoxic Therapy
- Acute Myeloid Leukemia With Multilineage Dysplasia
- Chronic Myelomonocytic Leukemia
- Myelodysplastic Syndrome
- Myeloproliferative Neoplasm
Interventions
- PROCEDURE
- DRUG